Cite
MLA Citation
Holger Fischer et al.. “Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein.” Neuro-oncology, vol. 22, no. 6, 2020, pp. 819–829. http://access.bl.uk/ark:/81055/vdc_100116596153.0x000021